S

Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581

Watchlist Manager
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Watchlist
Price: 13.51 CNY 4.24% Market Closed
Market Cap: 8.9B CNY
Have any thoughts about
Shandong Sinobioway Biomedicine Co Ltd?
Write Note

Shandong Sinobioway Biomedicine Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shandong Sinobioway Biomedicine Co Ltd
Operating Income Peer Comparison

Comparables:
546
G
9933
600989
600596
A
002597

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Shandong Sinobioway Biomedicine Co Ltd
SZSE:002581
Operating Income
-ÂĄ400.7m
CAGR 3-Years
-16%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Fufeng Group Ltd
HKEX:546
Operating Income
ÂĄ3.1B
CAGR 3-Years
47%
CAGR 5-Years
2%
CAGR 10-Years
N/A
G
GHW International
HKEX:9933
Operating Income
ÂĄ18.8m
CAGR 3-Years
-15%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
Operating Income
ÂĄ8.7B
CAGR 3-Years
2%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhejiang XinAn Chemical Industrial Group Co Ltd
SSE:600596
Operating Income
ÂĄ297.1m
CAGR 3-Years
-43%
CAGR 5-Years
-21%
CAGR 10-Years
-4%
A
Anhui Jinhe Industrial Co Ltd
SZSE:002597
Operating Income
ÂĄ626.6m
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
14%

See Also

What is Shandong Sinobioway Biomedicine Co Ltd's Operating Income?
Operating Income
-400.7m CNY

Based on the financial report for Jun 30, 2024, Shandong Sinobioway Biomedicine Co Ltd's Operating Income amounts to -400.7m CNY.

What is Shandong Sinobioway Biomedicine Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-12%

Over the last year, the Operating Income growth was -122%. The average annual Operating Income growth rates for Shandong Sinobioway Biomedicine Co Ltd have been -16% over the past three years , -12% over the past five years .

Back to Top